Both in Biotechnology
CG Oncology vs Adaptive Biotechnologies
Over the past year CGON returned +49.5% and ADPT returned +53.5%; their daily moves had a correlation of 0.19.
CGON +49.5% ADPT +53.5%Growth of $1, one year, split-adjusted
| Metric | CGON | ADPT |
|---|---|---|
| Price | $64.68 | $26.64 |
| Market cap | $5.73B | $4.25B |
| Today | +1.91% | −5.43% |
| 1 month | −5.4% | −2.7% |
| 6 months | −2.4% | +86.7% |
| Year to date | +55.8% | +64.0% |
| 1 year | +50.5% | +58.6% |
| Revenue growth (YoY) | — | +21.5% |
| Gross margin | −239.2% | 71.8% |
| Net margin | −6832.8% | −55.6% |
| P/E (TTM) | — | — |
| Price / sales | 920.6× | 13.8× |
| Net cash | $1.03B | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 40.3% | 50.5% |
| Short % of float | 12.9% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).